CTX TNA2 Cells
| Unit |
3 x 10^6 cells/ml |
|---|---|
| Cell Type |
Immortalized Cells |
| Tissue Type |
Rat cell lines |
| Organism |
Rat |
| Donor History | |
| Growth Properties |
Adherent |
| Growth Conditions |
Culture medium: DMEM ,w: 4.5 g/L Glucose ,w: 4 mM L-Glutamine ,w: 3.7 g/L NaHCO3 ,w: 1.0 mM Sodium pyruvate (Cytion article number 820300a). Supplements: Supplement the medium with 10% FBS. Dissociation reagent: Accutase. Freeze medium: As a cryopreservation medium ,we use 50% basal medium + 40% FBS + 10% DMSO ,or CM-1 (Cytion catalog number 800100) ,which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. Incubation atmosphere: 37°C ,5% CO2 ,humidified atmosphere. |
| Immortalization Method | |
| Full Information |
CTX TNA2 is a rat astrocyte cell line that was established from primary cultures of cortical astrocytes. It is often used to study central nervous system (CNS) functions, particularly in relation to glial biology, neurotoxicity, and neuroprotection. Astrocytes play a critical role in maintaining CNS homeostasis, providing structural and metabolic support to neurons, and mediating responses to injury and oxidative stress.
In various studies, CTX TNA2 cells have been employed to model neurotoxicity, especially involving excitotoxicity induced by agents such as glutamate. For instance, exposure to glutamate in CTX TNA2 cells triggers apoptosis and autophagy through mechanisms involving reactive oxygen species (ROS) and the glycogen synthase kinase-3β (GSK-3β) pathway. These pathways are central to the cells’ response to oxidative stress and mitochondrial dysfunction, particularly after traumatic brain injury or other neurodegenerative conditions. Additionally, neuroprotective agents like resveratrol and cannabidiol (CBD) have been shown to reduce ROS generation and inhibit glutamate-induced autophagy and apoptosis in these astrocytes.
The CTX TNA2 cell line has proven to be a valuable in vitro model for studying not only basic astrocyte function but also the therapeutic potential of antioxidant and neuroprotective compounds under conditions of CNS injury and disease.
Společnost Cytion vznikla v roce 2004 v německém Heidelbergu s jasným vědeckým posláním: dodávat ověřené lidské a zvířecí buněčné linie bez kontaminace, připravené za přísně kontrolovaných laboratorních podmínek.
Postupně se vypracovala ve spolehlivou buněčnou banku, která slouží akademickým laboratořím, biotechnologickým firmám i farmaceutickým výzkumným týmům po celém světě. Klade přitom důraz na reprodukovatelnost výsledků, přísnou kontrolu kvality a dlouhodobá partnerství.
Mikrobiologické aplikace
NGS
Rapid testy
PCR plasty
Třepačky
Suché lázně
Fluorometry
Buněčné kultury
PCR, qPCR, RT
Detekce Mycoplasmat
Reverzní transkripce
Alergie
Intolerance
Elisa
Imunologické analyzátory
Veterinární imunologie
Alergie u zvířat
Intolerance u zvířat
Čtečky identifikačních čipů
Termočipy
Biochemie
Imunoanalýza

